Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| InspireMD, Inc.NSPR · Entity 7318 | EVP Clinical/Medical Affairs | January 07, 2025 | January 10, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
InspireMD, Inc.
Report date January 07, 2025 · Filed January 10, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 311,532 |
Reported balance
After 2025-01-07 transaction · row 1
1 source rowRow 1 · 2025-01-07 · Grant · Acquired 83,072 · Balance 311,532 F1: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. |
| Options to purchase common stock (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.71 · Expires 2035-01-07 | Direct | 117,281 |
Reported balance
After 2025-01-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-01-07 · Grant · Acquired 37,933 · Balance 117,281 F2: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.
F2: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 37,933 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001734 · ownership.xml · derivative · entry 2 Verta Patrick · CIK 0001586025 · EVP Clinical/Medical Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,281 Underlying: Common Stock · 37,933 shares Expires 2035-01-07 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 83,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001734 · ownership.xml · nonDerivative · entry 1 Verta Patrick · CIK 0001586025 · EVP Clinical/Medical Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 311,532 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:53 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 32,768 | $0.00 Strike: $3.14 | $0.00 |
DisclosureSEC source: 0001493152-24-003775 · ownership.xml · derivative · entry 2 Verta Patrick · CIK 0001586025 · EVP Clinical/Medical Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,348 Underlying: Common Stock · 32,768 shares Expires 2034-01-23 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:53 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 85,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-003775 · ownership.xml · nonDerivative · entry 1 Verta Patrick · CIK 0001586025 · EVP Clinical/Medical Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,460 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.